Search results for "ADENOCARCINOMA"

showing 10 items of 589 documents

SIUMB recommendations for focal pancreatic lesions

2020

AbstractContrast-enhanced ultrasonography (CEUS) is increasingly being performed in Italy and Europe, particularly in the field of hepato-gastroenterology. Initially, it was mainly carried out to characterize focal hepatic lesions, but, since then, numerous studies have demonstrated its efficacy in the differential diagnosis of focal pancreatic pathologies (D’Onofrio et al. in Expert Rev Med Devices 7(2):257–273, 2010; Vidili et al. in J Ultrasound 22(1):41–51, 2019). The purpose of this paper is to provide Italian Medical Doctors with recommendations and thereby practical guidelines on the management of these patients. The present paper reports the final conclusions reached by the SIUMB gu…

Image-Guided Biopsymedicine.medical_specialtyPercutaneousContrast Media030218 nuclear medicine & medical imagingDiagnosis Differential03 medical and health sciencesPancreatic cystic lesion0302 clinical medicinePancreatic cancerCEUS; Contrast-enhanced ultrasound; Pancreas; Pancreatic adenocarcinoma; Pancreatic biopsy; Pancreatic cancer; Pancreatic cancer; Pancreatic cystic lesions; Ultrasound; Diagnosis Differential; Humans; Image-Guided Biopsy; Pancreatic Cyst; Pancreatic Neoplasms; Ultrasonography; Contrast MediaDiagnosisCEUS Ultrasound Contrast-enhanced ultrasound Pancreas Pancreatic adenocarcinoma Pancreatic cystic lesions Pancreatic biopsy Pancreatic cancerUltrasoundInternal MedicinemedicineHumansPancreaRadiology Nuclear Medicine and imagingPancreatic biopsyPancreasCEUS; Contrast-enhanced ultrasound; Pancreas; Pancreatic adenocarcinoma; Pancreatic biopsy; Pancreatic cancer; Pancreatic cancer; Pancreatic cystic lesions; UltrasoundUltrasonography030219 obstetrics & reproductive medicinebusiness.industryGeneral surgeryPancreatic biopsyGeneral MedicineGuidelinePancreatic cancermedicine.diseasePancreatic Neoplasmsmedicine.anatomical_structureDifferentialCEUSOriginal ArticleCEUS; Contrast-enhanced ultrasound; Pancreas; Pancreatic adenocarcinoma; Pancreatic biopsy; Pancreatic cancer; Pancreatic cystic lesions; UltrasoundUltrasonographyDifferential diagnosisPancreatic CystbusinessPancreasPancreatic adenocarcinomaContrast-enhanced ultrasoundContrast-enhanced ultrasoundPancreatic cystic lesions
researchProduct

Complex Cellular Responses of Helicobacter pylori-Colonized Gastric Adenocarcinoma Cells ▿

2011

ABSTRACT Helicobacter pylori is an important class I carcinogen that persistently infects the human gastric mucosa to induce gastritis, gastric ulceration, and gastric cancer. H. pylori pathogenesis strongly depends on pathogenic factors, such as VacA (vacuolating cytotoxin A) or a specialized type IV secretion system (T4SS), which injects the oncoprotein CagA (cytotoxin-associated gene A product) into the host cell. Since access to primary gastric epithelial cells is limited, many studies on the complex cellular and molecular mechanisms of H. pylori were performed in immortalized epithelial cells originating from individual human adenocarcinomas. The aim of our study was a comparative anal…

ImmunologyImmunoblottingAdenocarcinomaMicrobiologyHelicobacter InfectionsStomach NeoplasmsCell Line TumormedicineGastric mucosaCell AdhesionCagAHumansImmunoprecipitationSecretionInterleukin 8Cell adhesionAuthor CorrectionbiologyHelicobacter pyloriReverse Transcriptase Polymerase Chain ReactionInterleukin-8Bacterial InfectionsHelicobacter pylorimedicine.diseasebiology.organism_classificationbacterial infections and mycosesdigestive system diseasesInfectious Diseasesmedicine.anatomical_structureCell cultureBacterial TranslocationImmunologyHost-Pathogen InteractionsCancer researchAdenocarcinomaParasitology
researchProduct

Mapping of the perigastric lymphatic network using indocyanine green fluorescence imaging and tissue marking dye in clinically advanced gastric cance…

2022

Abstract Background Using indocyanine green (ICG) fluorescence imaging and tissue marking dyes (TMDs), perigastric lymphatic mapping and their pathological correlation were examined to see whether ICG staining covers all metastatic lymph nodes (LNs) in advanced gastric cancer (AGC). Methods Patients with AGC who underwent open distal or total gastrectomy were enrolled. ICG was serially injected intraoperatively into the subserosa along the greater and lesser curvatures. Stomach specimens were examined under a near-infrared camera. ICG-stained LNs were named, excised, and tattooed with different colored TMDs to retrace the exact location after pathological examinations. Results A total of 68…

Indocyanine GreenMalegenetic structuresmedicine.medical_treatmentAdenocarcinomaLymphatic Systemchemistry.chemical_compoundGastrectomyStomach NeoplasmsmedicineHumansColoring AgentsAgedAged 80 and overIntraoperative Careintegumentary systembusiness.industryStomachOptical ImagingGeneral MedicinePerigastricMiddle Agedeye diseasesbody regionsDissectionmedicine.anatomical_structureLymphatic systemOncologychemistryLymphatic MetastasisSubserosaLymph Node ExcisionSurgeryGastrectomyFemaleLymphLymph NodesNuclear medicinebusinessIndocyanine greenEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
researchProduct

Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells

2020

A new series of eighteen imidazo [2,1-b] [1,3,4]thiadiazole derivatives was efficiently synthesized and screened for antiproliferative activity against the National Cancer Institute (NCI-60) cell lines panel. Two out of eighteen derivatives, compounds 12a and 12h, showed remarkably cytotoxic activity with the half maximal inhibitory concentration values (IC50) ranging from 0.23 to 11.4 μM, and 0.29–12.2 μM, respectively. However, two additional compounds, 12b and 13g, displayed remarkable in vitro antiproliferative activity against pancreatic ductal adenocarcinoma (PDAC) cell lines, including immortalized (SUIT-2, Capan-1, Panc-1), primary (PDAC-3) and gemcitabine-resistant (Panc-1R), elici…

Inhibition of migrationAntimetabolites AntineoplasticEpithelial-Mesenchymal Transition3Modulation of EMTPTK2VimentinAntineoplastic AgentsApoptosisThiophenesAntiproliferative activity1-b][1DeoxycytidinePancreatic ductal adenocarcinomaThiadiazolesSDG 3 - Good Health and Well-beingCell MovementPancreatic cancerDrug DiscoveryThiadiazolesmedicineTumor Cells CulturedImidazo[21-b][134]thiadiazole derivativesHumansPTK2/FAKIC50Cell ProliferationImidazo[2Pharmacologybiology4]thiadiazole derivativesChemistryOrganic ChemistryDrug SynergismGeneral Medicinemedicine.diseaseGemcitabinePancreatic NeoplasmsCell cultureDrug Resistance NeoplasmImidazo[21-b][134]thiadiazole derivatives Pancreatic ductal adenocarcinoma Antiproliferative activity Inhibition of migration Spheroids shrinkage Modulation of EMT PTK2/FAKbiology.proteinCancer research/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingPhosphorylationSpheroids shrinkageTyrosine kinaseCarcinoma Pancreatic DuctalEuropean Journal of Medicinal Chemistry
researchProduct

Early-stage small-bowel adenocarcinoma: a review of local endoscopic therapy.

2005

Early adenocarcinomas in the small intestine are a rare entity. Most adenocarcinomas in the small intestine are diagnosed at a more advanced stage. After surgical resection, only 3 - 10 % are found in stage T1 and 0 - 3 % in stage Tis (high-grade intraepithelial neoplasia), resulting in an overall 3 - 13 % rate of early-stage small-intestinal adenocarcinomas. The diagnosis of early small-intestinal carcinoma by endoscopy is still very rare, although it will probably improve with the development of new endoscopic techniques. At present there have been only two studies and a few case reports on the treatment of early duodenal carcinoma by endoscopic resection. No major complications such as m…

Intraepithelial neoplasiamedicine.medical_specialtymedicine.diagnostic_testbusiness.industryPerforation (oil well)GastroenterologyAdenocarcinomamedicine.diseaseEndoscopy GastrointestinalSurgeryEndoscopymedicine.anatomical_structureDuodenal NeoplasmsSubmucosaLymphatic MetastasisIntestinal NeoplasmsmedicineCarcinomaAdenocarcinomaDuodenal CarcinomaHumansStage (cooking)businessNeoplasm StagingEndoscopy
researchProduct

An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated an…

2009

Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease with a very poor 5-year survival rate. alpha-Enolase is a glycolytic enzyme that also acts as a surface plasminogen receptor. We find that it is overexpressed in PDAC and present on the cell surface of PDAC cell lines. The clinical correlation of its expression with tumor status has been reported for lung and hepatocellular carcinoma. We have previously demonstrated that sera from PDAC patients contain IgG autoantibodies to alpha-enolase. The present work was intended to assess the ability of alpha-enolase to induce antigen-specific T cell responses. We show that alpha-enolase-pulsed dendritic cells (DC) specifically stimulate healt…

KeratinocytesCancer ResearchPancreatic diseaseendocrine system diseasesalpha-enolaseAntibodies NeoplasmAlpha-enolaseT-LymphocytesMiceSkinImmunity Cellularhuman; pancreatic ductal adenocarcinoma; alpha enolase; tumor antigen; B cell response; T cell responsebiologyalpha enolasehuman; pancreatic ductal adenocarcinoma; alpha-enolase; tumor antigen; B cell response; T cell responseImmunohistochemistryTumor antigenUp-RegulationGene Expression Regulation Neoplasticmedicine.anatomical_structureOncologyAntibodyCarcinoma Pancreatic DuctalB cell responseT cellBlotting Westernpancreatic ductal adenocarcinomaGene Expression Regulation EnzymologicInterferon-gammaImmune systemAntigenAntigens NeoplasmCell Line TumorPancreatic cancermedicineAnimalsHumanshumanPancreasCell ProliferationDendritic Cellsmedicine.diseaseT cell responsepancreatic ductal adenocarcinoma; alpha-enolase; tumor antigen.digestive system diseasesPancreatic NeoplasmsImmunoglobulin GPhosphopyruvate HydrataseAntibody FormationImmunologybiology.proteintumor antigenT-Lymphocytes Cytotoxic
researchProduct

Two rare cases of oral metastasis arising from lung adenocarcinoma and esophageal carcinoma

2020

Metastasis to the oral cavity are rare, representing only 1% of all oral malignancies, and originate from various sites such as the breast, prostate, lung and kidney. Clinically, they can simulate reactive and inflammatory lesions common in the oral cavity, and the clinical and microscopic diagnosis of these metastasis is a challenge. In this article, we report two new cases of esophageal and lung metastasis to oral tissues, highlighting their clinical characteristics and the process of diagnostic elucidation. We emphasize the importance for clinicians to consider the possibility of metastatic lesions in the oral cavity in patients previously diagnosed with malignant lesions in distant tiss…

KidneyPathologymedicine.medical_specialtyOral Medicine and PathologyLungbusiness.industryLung metastasisCase Report030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseMetastasisstomatognathic diseases03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureProstate030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASCarcinomaMedicineAdenocarcinomaIn patientbusinessGeneral DentistryJournal of Clinical and Experimental Dentistry
researchProduct

Apigenin affects leptin/leptin receptor pathway and induces cell apoptosis in lung adenocarcinoma cell line

2011

Abstract Background Apigenin, a common edible plant flavonoid, is a well characterised antioxidant. The adipokine leptin exerts proliferative and anti-apoptotic activities in a variety of cell types. In cancer cells, apigenin may induce a pro-apoptotic pathway whereas leptin has an anti-apoptotic role. The purpose of the study is to investigate the role of apigenin and of leptin/leptin receptor pathway on proliferation and on apoptosis in lung adenocarcinoma. Methods Immunocytochemistry, flow cytometry and RT-q-RT PCR, were used to investigate the expression and modulation of leptin receptors on the lung adenocarcinoma cell line A549 in presence or absence of apigenin and of leptin, alone o…

LeptinApigenin Apoptosis Leptin Lung cancerROSCancer Researchmedicine.medical_specialtyProgrammed cell deathLung NeoplasmsCell SurvivalAdipokineAdenocarcinoma of LungApoptosisCell Growth ProcessesAdenocarcinomaSettore MED/10 - Malattie Dell'Apparato RespiratorioBiologySettore BIO/09 - Fisiologiachemistry.chemical_compoundCell Line TumorInternal medicinemedicineHumansApigeninReceptorLeptin receptorCell growthLeptindigestive oral and skin physiologyEndocrinologyOncologychemistryApoptosisApigeninReceptors Leptinhormones hormone substitutes and hormone antagonistsEuropean Journal of Cancer
researchProduct

Pilot Study on Predictive Value of Plasmatic Levels of 9 Angiogenetic Biomarkers in Selection of Patients Candidate to Prostate Biopsy

2013

To reduce the number of negative prostate biopsies in patients with elevated PSA serum levels represents a major challenge in urological oncology. Angiogenetic factors might be involved in initial stages of prostate cancer and might represent useful tools in patients’ selection for prostate biopsy. The plasmatic levels of Angiopoietin-2, Follistatin, G-CSF, HGF, IL-8, Leptin, PDGF-BB, PECAM-1 and VEGF were measured by BioPlex immunoassay in patients undergoing prostate biopsy for palpable prostate nodule and/or elevated PSA levels (≥4 ng/mL). They were related with biopsy results. ROC curve analysis was exploited to test the diagnostic accuracy of each biomarker by AUC calculation. A poten…

LeptinMaleOncologymedicine.medical_specialtyPathologyProstate biopsyBiopsyPilot ProjectsAdenocarcinomaUrological oncologyProstate cancerPredictive Value of TestsProstateInternal medicineBiomarkers TumormedicineHumansIn patientAngiogenic ProteinsAgedAged 80 and overProstatic Intraepithelial Neoplasiamedicine.diagnostic_testbusiness.industryPatient SelectionProstateProstatic NeoplasmsGeneral MedicineMiddle AgedProstate-Specific Antigenmedicine.diseaseElevated PSAPredictive valuemedicine.anatomical_structureROC CurveArea Under CurveNeoplasm GradingbusinessUrologia Journal
researchProduct

Characterisation of the essential oil of Nepeta glomerata Montbret et Aucher ex Bentham from Lebanon and its biological activities.

2011

The essential oil of Nepeta glomerata from Lebanon was studied by means of GC and GC/MS analysis; 70 compounds were identified. The oil was constituted mainly by monoterpenes and the most abundant components were α-pinene, spathulenol and carvacrol. Nepeta glomerata oil showed antibacterial activity, particularly towards Gram-positive bacteria, and also inhibited LPS-induced NO production in macrophage cell line RAW 264.7, with an IC(50) value of 78.1 µg mL(-1). Furthermore, an in vitro cytotoxic assay showed that the oil was more active on a renal adenocarcinoma cell line (48% of inhibition of proliferation at 100 µg mL(-1)) in comparison to an amelanotic melanoma.

LipopolysaccharidesPlant ScienceMicrobial Sensitivity TestsNitric OxideBiochemistryAnalytical Chemistrylaw.inventionchemistry.chemical_compoundMicelawNepetaCell Line TumorBotanyOils VolatileAnimalsHumansCarvacrolNo productionLebanonEssential oilbiologyOrganic ChemistryMs analysisbiology.organism_classificationAnti-Bacterial AgentschemistryMonoterpenesNepetaRenal adenocarcinomaDrug Screening Assays AntitumorAntibacterial activityBacteriaNatural product research
researchProduct